The landscape of dementia analysis has advanced dramatically with the advent of advanced biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology several years ahead of indicators emerge. While these technological innovations characterize amazing development in knowing neurodegenerative illnesses, they have not https://rebeccap641nwg0.eedblog.com/profile